Androgenetic alopecia, a slow progressive form of alopecia, begins after the onset of puberty. Pattern or androgenetic alopecia is a genetically predetermined disorder due to excessive response to androgens that affects up to 50% of males and females globally, according to the National Center for Biotechnology Information (NCBI). It is characterized by progressive loss of terminal hair of the scalp, in a characteristic distribution in both males and females. In males, hair loss is most prominent in the vertex and frontotemporal regions, while in women the frontal hairline is typically spared with diffuse apical hair loss noted as a wider anterior part of the hair.
Market Dynamics
Rising incidence of androgenetic alopecia is expected to drive the global androgenetic alopecia treatment market growth. According to the National Library of Medicine (NLM), a medical library which is part of the National Institutes of Health (NIH), androgenetic alopecia affects approximately 50 million men and 30 million women in the U.S.
However, availability of alternative treatments is expected to hinder the market growth. For instance, hair restoration surgery such as scalp reduction surgeries, which is not used frequently but efficacy of hair transplantation is based on the principle of donor dominance.
Key features of the study
• This report provides in-depth analysis of the global androgenetic alopecia treatment market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global androgenetic alopecia treatment market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study are Histogen Inc., Cipla Limited, Aclaris Therapeutics, Inc., Merck & Co., Inc., Daiichi-Sankyo Co., Ltd., Johnson and Johnson Services, Inc., Lexington International LLC, Vita-Cos-Med Klett-Loch GmbH, PureTech, Vitabiotics, Dr. Reddy’s Laboratories, HCell Inc., Follica, Inc. and Ranbaxy Laboratories Ltd. among others
• Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
• The global androgenetic alopecia treatment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global androgenetic alopecia treatment market.
Market Segmentation
• By Drug Type (Revenue, USD Bn, 2021-2033)
o Topical Agents
o 5 AR Inhibitors
o Others
• By Route of Administration (Revenue, USD Bn, 2021-2033)
o Oral
o Topical
• By Gender (Revenue, USD Bn, 2021-2033)
o Male
o Female
• By Distribution Channel (Revenue, USD Bn, 2021-2033)
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
• By Region (Revenue, USD Bn, 2021-2033)
o North America
 U.S.
 Canada
o Latin America
 Brazil
 Mexico
 Argentina
 Rest of Latin America
o Europe
 Germany
 U.K.
 France
 Italy
 Spain
 Russia
 Rest of Europe
o Asia Pacific
 China
 India
 Japan
 Australia
 South Korea
 ASEAN
 Rest of Asia Pacific
o Middle East
 GCC
 Israel
 Rest of Middle East
o Africa
 South Africa
 Central Africa
 North Africa
• Key Players
o Histogen Inc.
o Cipla Limited
o Aclaris Therapeutics, Inc.
o Merck & Co., Inc.
o Daiichi-Sankyo Co., Ltd.
o Johnson and Johnson Services, Inc.
o Lexington International LLC
o Vita-Cos-Med Klett-Loch GmbH
o PureTech
o Vitabiotics
o Reddy’s Laboratories
o HCell Inc.
o Follica, Inc.
o Ranbaxy Laboratories Ltd.

Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
 Market Definition and Scope
o Executive Summary
 Global Androgenetic Alopecia Treatment Market, By Drug Type
 Global Androgenetic Alopecia Treatment Market, By Route of Administration
 Global Androgenetic Alopecia Treatment Market, By Gender
 Global Androgenetic Alopecia Treatment Market, By Distribution Channel
 Global Androgenetic Alopecia Treatment Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Product Launches/Approvals
o PEST Analysis
o PORTER’s Analysis
o Market Opportunities
o Regulatory Scenario
o Key Developments
o Industry Trend
4. Global Androgenetic Alopecia Treatment Market, By Drug Type, 2021-2033, (USD Bn)
o Introduction
 Market Share Analysis, 2026 and 2033 (%)
 Y-o-Y Growth Analysis, 2022 - 2033
 Segment Trends
o Topical Agents
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o 5 AR Inhibitors
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Others
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Androgenetic Alopecia Treatment Market, By Route of Administration, 2021-2033, (USD Bn)
o Introduction
 Market Share Analysis, 2026 and 2033 (%)
 Y-o-Y Growth Analysis, 2022 - 2033
 Segment Trends
o Oral
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Topical
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Androgenetic Alopecia Treatment Market, By Gender, 2021-2033, (USD Bn)
o Introduction
 Market Share Analysis, 2026 and 2033 (%)
 Y-o-Y Growth Analysis, 2022 - 2033
 Segment Trends
o Male
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Female
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Androgenetic Alopecia Treatment Market, By Distribution Channel, 2021-2033, (USD Bn)
o Introduction
 Market Share Analysis, 2026 and 2033 (%)
 Y-o-Y Growth Analysis, 2022 - 2033
 Segment Trends
o Hospital Pharmacies
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Retail Pharmacies
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Online Pharmacies
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Androgenetic Alopecia Treatment Market, By Region, 2021 - 2033, Value (USD Bn)
o Introduction
 Market Share (%) Analysis, 2026 & 2033, Value (USD Bn)
 Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
 Regional Trends
o North America
 Introduction
 Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)
 Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
 Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
 Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
 Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
o U.S.
o Canada
o Latin America
 Introduction
 Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)
 Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
 Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
 Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
 Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Europe
 Introduction
 Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)
 Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
 Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
 Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
 Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
o Germany
o U.K.
o Spain
o France
o Italy
o Russia
o Rest of Europe
o Asia Pacific
 Introduction
 Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)
 Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
 Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
 Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
 Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
 Introduction
 Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)
 Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
 Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
 Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
 Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
 Introduction
 Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)
 Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
 Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
 Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
 Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
o South Africa
o North Africa
o Central Africa
9. Competitive Landscape
o Histogen Inc.
 Company Highlights
 Product Portfolio
 Key Developments
 Financial Performance
 Strategies
o Cipla Limited
 Company Highlights
 Product Portfolio
 Key Developments
 Financial Performance
 Strategies
o Aclaris Therapeutics, Inc.
 Company Highlights
 Product Portfolio
 Key Developments
 Financial Performance
 Strategies
o Merck & Co., Inc.
 Company Highlights
 Product Portfolio
 Key Developments
 Financial Performance
 Strategies
o Daiichi-Sankyo Co., Ltd.
 Company Highlights
 Product Portfolio
 Key Developments
 Financial Performance
 Strategies
o Johnson and Johnson Services, Inc.
 Company Highlights
 Product Portfolio
 Key Developments
 Financial Performance
 Strategies
o Lexington International LLC
 Company Highlights
 Product Portfolio
 Key Developments
 Financial Performance
 Strategies
o Vita-Cos-Med Klett-Loch GmbH
 Company Highlights
 Product Portfolio
 Key Developments
 Financial Performance
 Strategies
o PureTech
 Company Highlights
 Product Portfolio
 Key Developments
 Financial Performance
 Strategies
o Vitabiotics
 Company Highlights
 Product Portfolio
 Key Developments
 Financial Performance
 Strategies
o Dr. Reddy’s Laboratories
 Company Highlights
 Product Portfolio
 Key Developments
 Financial Performance
 Strategies
o HCell Inc.
 Company Highlights
 Product Portfolio
 Key Developments
 Financial Performance
 Strategies
o Follica, Inc.
 Company Highlights
 Product Portfolio
 Key Developments
 Financial Performance
 Strategies
o Ranbaxy Laboratories Ltd.
 Company Highlights
 Product Portfolio
 Key Developments
 Financial Performance
 Strategies
10. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
11. References and Research Methodology
o References
o Research Methodology
o About us